Many studies have reported that PSA nadir and time to PSA nadir (TTN) are factors that predict the prognosis of prostate cancer in patients after ADT [26,27,28]; however, PSA nadir and TTN require long-term observation and are not useful for early prognosis prediction. The gene discussed is KLK3; the disease is prostate carcinoma.